Vireo Growth (VREOF) Other Working Capital Changes (2021)

Vireo Growth (VREOF) posted Other Working Capital Changes of -$556219.0 for Q4 2021.

Vireo Growth (VREOF) Other Working Capital Changes (2021) Analysis & Trends

Vireo Growth has reported Other Working Capital Changes for 1 years, with the latest figure at -$556219.0 in Q4 2021.

Quarterly Other Working Capital Changes fell 225.0% year-over-year to -$1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.0 million (down 688.6% YoY) and the FY2025 annual result came in at -$3.1 million, down 1021.03% from the prior year.
Other Working Capital Changes fell to -$1.3 million in Q1 2026 per VREOF's latest filing, from -$1.3 million in the prior quarter.
Over five years, Other Working Capital Changes peaked at $126705.0 in Q4 2024 and troughed at -$1.3 million in Q1 2026.
A 3-year average of -$521404.7 and a median of -$400000.0 in 2025 frame the typical range for Other Working Capital Changes.
The widest YoY moves for Other Working Capital Changes: up 137.04% in 2025, down 1114.76% in 2025.
Over 3 years, Other Working Capital Changes stood at $126705.0 in 2024, then sank by 1114.76% to -$1.3 million in 2025, then declined by 1.11% to -$1.3 million in 2026.
According to Business Quant data, Other Working Capital Changes over the past three periods registered -$1.3 million, -$1.3 million, and -$997728.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.65 Bn	42.68 Bn	-
2	Teva Pharmaceutical Industries	43.09 Bn	39.44 Bn	2.15 Bn
3	Zoetis	31.54 Bn	29.86 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.61 Bn	22.81 Bn	5.10 Bn
5	United Therapeutics	22.11 Bn	19.45 Bn	683.80 Mn
6	Viatris	18.77 Bn	17.88 Bn	1.46 Bn
7	Neurocrine Biosciences	15.62 Bn	15.23 Bn	935.80 Mn
8	Elanco Animal Health	12.07 Bn	11.54 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.09 Bn	9.93 Bn	-
10	Vireo Growth	492.35 Mn	350.05 Mn	95.30 Mn

Download Data